Mersana Therapeutics Inc (MRSN) valuation · rev $40.5M
Mersana Therapeutics Inc (MRSN) rev $40.5M.
| Metric | Value |
|---|---|
| Market cap | $145.4M |
| Revenue | $40.5M |
| P/S | 3.6 |
| P/B | 32.0 |
MRSN valuation FAQ
What is MRSN's market cap?
Mersana Therapeutics Inc (MRSN) market cap is $145.4M on the latest cached fundamentals snapshot.
What is MRSN's latest revenue?
Latest cached Mersana Therapeutics Inc (MRSN) revenue was $40.5M. Statements: https://lician.com/financials/mrsn
What is MRSN's price-to-sales ratio?
Mersana Therapeutics Inc (MRSN) price-to-sales (P/S) is 3.6, cached market cap $145.4M divided by revenue $40.5M.
What is MRSN's price-to-book ratio?
Mersana Therapeutics Inc (MRSN) price-to-book (P/B) is 32.0 on the latest cached fundamentals snapshot.
How many MRSN valuation scalars are listed on this page?
This page lists 4 cached valuation scalars for Mersana Therapeutics Inc (MRSN): Market cap, Revenue, P/S, and P/B.
Where is MRSN valuation listed?
Cached valuation multiples for Mersana Therapeutics Inc (MRSN) are listed at https://lician.com/valuation/mrsn.
Not investment advice. Cached rows, not a live tape.